Results 11 to 20 of about 1,163 (152)
The pharmacological deprescription in elderly patients
Italian Journal of Medicine, 2023 The demographic of individuals aged 65 and above represents one of the fastest-growing populations globally. As of 2020, there were 727 million individuals (9.3%) aged 65 years or older worldwide.
Chelsey Ali +4 more
doaj +2 more sources
Practical Considerations of PRN Medicines Management: An Integrative Systematic Review [PDF]
Frontiers in Pharmacology, 2022 Background and objectives: Highly widespread use of pro re nata (PRN) medicines in various healthcare settings is a potential area for improper medication prescription and administration leading to patient harm.
Abbas Mardani +5 more
doaj +6 more sources
Barriers and enablers to opioid deprescription: A qualitative study.
PLoS ONEBackgroundCanada has the fourth highest per capita rate of opioid prescriptions in the world, contributing to the country's opioid crisis. Due to both their pain-relieving and euphoric properties, opioids can be highly addictive, leading to potential ...
Rebecca Lawrence +4 more
doaj +4 more sources
Benzodiazepine deprescription strategies in chronic users: a systematic review
Family Practice, 2021 AbstractBackgroundAs long-term use of benzodiazepines increases, adverse effects also become more frequent, especially in elderly adults. Due the potential of causing dependence, poor patient adherence and a lack of awareness of side effects, deprescription is challenging.ObjectiveThis study aimed to identify what are the effective approaches to ...
Péricles Ricardo de Souza Ribeiro +1 more
exaly +3 more sources
Pharmaceuticals, 2023 The prescriptive appropriateness of Proton Pump Inhibitors (PPIs) in polypharmacy is controversial. PPIs are often overprescribed and the risk of prescribing errors and adverse drug reactions increases for each additional drug added to therapy.
Giammarco Baiardi +7 more
doaj +3 more sources
The Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicians
Healthcare (Switzerland), 2023 Background and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who care for multipathological patients.
Marta Mejías Trueba +2 more
exaly +6 more sources
Deprescription on oncological palliative care: an integrating review
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2019 Background: Patients on oncologic palliative care (OPC), due to diverse symptomatology and variable severity, tend to present polypharmacy that, although it seems justifiable in many cases, can pose health risks and negative consequences on patients ...
Ana P. Antonio +3 more
doaj +3 more sources
Atención Primaria, 2018 Resumen: La creciente longevidad de la población, el aumento de la morbilidad y del consumo de medicamentos han provocado que la polimedicación sea un problema de salud prioritario por sus consecuencias en el incremento de efectos adversos, interacciones
Óscar Esteban Jiménez +5 more
doaj +4 more sources
BMC Primary CareBackground Polypharmacy is easily achieved in elderly patients with multimorbidity and it is associated with a higher risk of potentially inappropriate medication use and worse health outcomes.
Tânia Coelho +2 more
exaly +2 more sources
Deprescription in Palliative Care
Cureus, 2023 Individuals with limited life expectancy represent a significant proportion of healthcare consumers and are usually patients with multiple diseases and high levels of frailty. Polypharmacy and the prescription of long lists of drugs are frequent in patients with reduced life expectancy and often, as the patient's health status deteriorates, the list of
Cabrera, Joana A +3 more
openaire +2 more sources